首页> 美国卫生研究院文献>Bioinorganic Chemistry and Applications >Synthesis Structure Properties And Biological Behaviour Of The Complex RuIV (H2L) Cl2.2H2O(H4L= 12-Cyclohexanediamminetetraacetic Acid)
【2h】

Synthesis Structure Properties And Biological Behaviour Of The Complex RuIV (H2L) Cl2.2H2O(H4L= 12-Cyclohexanediamminetetraacetic Acid)

机译:RuIV(H2L)Cl2 .2H2O配合物的合成结构性质和生物学行为(H4L = 12-环己烷二氨四乙酸)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The highly water-soluble ruthenium complex [Ru(H2L)Cl2]2H2o, in which H4L is the sequestering ligand trans-l, 2-cyclohexanediamminetetraacetic acid (cdta) has been synthesized, structurally characterized and its properties studied. The X-ray crystallographic study shows that the chelating coordinated ligand is tetradentate while the ruthenium environment is octahedral and slightly distorted, with two chloride anions coordinated in cis positions. Potentiometric, conductimetric and infrared studies confirm the presence of two free carboxylic groups, while electronic and voltammetric studies show that the central ion is Ru(IV). The testing of the cytotoxic activity of this complex against three different human cancer cell lines indicates that [Ru(H2L)Cl2].2H2O shows a remarkable and selective antiproliferative effect against the human uterine neck carcinoma HeLa and the malign adenocarcinoma ADLD, showing only a discrete turnout cell inhibition activity against colon adenocarcinoma HT-29. The important antiprotiferative behaviour of complex 1 against the human adenocarcinoma ADLD, indicates that [Ru(H2L)Cl2].2H2O might be considered as potential antineoplastic compound.
机译:已经合成了高度水溶性的钌络合物[Ru(H2L)Cl2] 2H2o,其中H4L是螯合的反式配体,即2-环己烷二氨四乙酸(cdta),并对其结构进行了表征,并对其性质进行了研究。 X射线晶体学研究表明,螯合配位配体为四齿,而钌环境为八面体且略微扭曲,两个氯离子在顺式位置进行配位。电位,电导和红外研究证实了两个游离羧基的存在,而电子和伏安研究表明中心离子为Ru(IV)。测试该复合物对三种不同人类癌细胞系的细胞毒活性表明,[Ru(H2L)Cl2] .2H2O对人类宫颈癌HeLa和恶性腺癌ADLD表现出显着的选择性抗增殖作用,仅显示对结肠腺癌HT-29的离散离散细胞抑制活性。配合物1对人腺癌ADLD的重要抗增殖作用表明[Ru(H2L)Cl2] .2H2O可能被认为是潜在的抗肿瘤化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号